Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Tulane University
mi
from
New Orleans, LA
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Tulane University
mi
from
New Orleans, LA
Click here to add this to my saved trials
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Joslin Diabetes Center
mi
from
Boston, MA
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Kaleida Health Center
mi
from
Buffalo, NY
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Kaleida Health Center
mi
from
Buffalo, NY
Click here to add this to my saved trials
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
North Shore Diabetes and Endocrine Associates
mi
from
New Hyde Park, NY
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
North Shore Diabetes and Endocrine Associates
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Columbia University
mi
from
New York, NY
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Univ of Rochester Medical Center
mi
from
Rochester, NY
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Univ of North Carolina
mi
from
Chapel Hill, NC
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
University of Texas Southwestern
mi
from
Dallas, TX
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
University of Texas Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
University of Alabama
mi
from
Birmingham, AL
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
University of California, San Diego
mi
from
San Diego, CA
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Chapel Medical Group
mi
from
New Haven, CT
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Chapel Medical Group
mi
from
New Haven, CT
Click here to add this to my saved trials
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Emory University School of Medicine
mi
from
Atlanta, GA
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Kaiser Permanente
mi
from
Tucker, GA
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Kaiser Permanente
mi
from
Tucker, GA
Click here to add this to my saved trials
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Indiana University
mi
from
Indianapolis, IN
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Tulane University Health Sciences Center
mi
from
New Orleans, LA
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Tulane University Health Sciences Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Medstar Research Institute
mi
from
Hyattsville, MD
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Medstar Research Institute
mi
from
Hyattsville, MD
Click here to add this to my saved trials
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Dr. Rudo, Westminster, MD
mi
from
Westminster, MD
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Dr. Rudo, Westminster, MD
mi
from
Westminster, MD
Click here to add this to my saved trials
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Joslin Diabetes Center
mi
from
Boston, MA
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
University of Michigan
mi
from
Ann Arbor, MI
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
North Shore Diabetes and Endocrine Associates
mi
from
New Hyde Park, NY
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
North Shore Diabetes and Endocrine Associates
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Columbia University
mi
from
New York, NY
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Lang Medical Center
mi
from
Queens, NY
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Lang Medical Center
mi
from
Queens, NY
Click here to add this to my saved trials
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Albert Einstein College of Medicine
mi
from
The Bronx, NY
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Albert Einstein College of Medicine
mi
from
The Bronx, NY
Click here to add this to my saved trials
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Carolinas Health Care
mi
from
Charlotte, NC
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Carolinas Health Care
mi
from
Charlotte, NC
Click here to add this to my saved trials
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
University of North Carolina
mi
from
Durham, NC
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
University of North Carolina
mi
from
Durham, NC
Click here to add this to my saved trials
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
University of Texas Southwestern
mi
from
Dallas, TX
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
University of Texas Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated:  11/8/2017
Scott & White
mi
from
Temple, TX
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
Status: Enrolling
Updated: 11/8/2017
Scott & White
mi
from
Temple, TX
Click here to add this to my saved trials
Effect of Closed Loop Glucose Control on Exercise-Associated Hypoglycemia
Effect of Closed Loop Glucose Control on Exercise-Associated Hypoglycemia
Status: Enrolling
Updated:  11/9/2017
Yale Pediatrics Diabetes Research
mi
from
New Haven, CT
Effect of Closed Loop Glucose Control on Exercise-Associated Hypoglycemia
Effect of Closed Loop Glucose Control on Exercise-Associated Hypoglycemia
Status: Enrolling
Updated: 11/9/2017
Yale Pediatrics Diabetes Research
mi
from
New Haven, CT
Click here to add this to my saved trials
Treatment of Diabetes and Depression in Hispanics and African Americans and Its Effect on A1c and Quality of Life.
Effect of Pharmacological Treatment of Depression on A1C and Quality of Life in Underserved Hispanics and African Americans With Diabetes: A Randomized, Placebo Controlled Trial.
Status: Enrolling
Updated:  11/9/2017
Charles Drew University
mi
from
Los Angeles, CA
Treatment of Diabetes and Depression in Hispanics and African Americans and Its Effect on A1c and Quality of Life.
Effect of Pharmacological Treatment of Depression on A1C and Quality of Life in Underserved Hispanics and African Americans With Diabetes: A Randomized, Placebo Controlled Trial.
Status: Enrolling
Updated: 11/9/2017
Charles Drew University
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Vitamin D Supplementation on Cardiovascular Risk Factors
The Effect of Vitamin D Supplementation on Cardiovascular Risk Factors Among Hispanics and African Americans With Type 2 Diabetes
Status: Enrolling
Updated:  11/13/2017
Human Nutrition Laboratory, Florida International University
mi
from
Miami, FL
Vitamin D Supplementation on Cardiovascular Risk Factors
The Effect of Vitamin D Supplementation on Cardiovascular Risk Factors Among Hispanics and African Americans With Type 2 Diabetes
Status: Enrolling
Updated: 11/13/2017
Human Nutrition Laboratory, Florida International University
mi
from
Miami, FL
Click here to add this to my saved trials
Inpatient Closed-loop Glucose Control
Subcutaneous Continuous Glucose Monitoring and Intravenous Dosing of Insulin and Dextrose for Automated Glycemic Control in the Inpatient Setting
Status: Enrolling
Updated:  11/13/2017
MGH Diabetes Research Center
mi
from
Boston, MA
Inpatient Closed-loop Glucose Control
Subcutaneous Continuous Glucose Monitoring and Intravenous Dosing of Insulin and Dextrose for Automated Glycemic Control in the Inpatient Setting
Status: Enrolling
Updated: 11/13/2017
MGH Diabetes Research Center
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated:  11/13/2017
Clinical Research Facility
mi
from
Miami Lakes, FL
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Clinical Research Facility
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated:  11/13/2017
Clinical Research Facility
mi
from
Morehead City, NC
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Clinical Research Facility
mi
from
Morehead City, NC
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated:  11/13/2017
Research Site
mi
from
Munroe Falls, OH
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Research Site
mi
from
Munroe Falls, OH
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated:  11/13/2017
Clinical Research Facility
mi
from
Canoga Park, CA
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Clinical Research Facility
mi
from
Canoga Park, CA
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated:  11/13/2017
Clinical Research Facility
mi
from
Chino, CA
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Clinical Research Facility
mi
from
Chino, CA
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated:  11/13/2017
Clinical Research Facility
mi
from
Huntington Park, CA
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Clinical Research Facility
mi
from
Huntington Park, CA
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated:  11/13/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated:  11/13/2017
Clinical Research Facility
mi
from
San Diego, CA
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated:  11/13/2017
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated:  11/13/2017
Clinical Research Facility
mi
from
Hialeah, FL
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated:  11/13/2017
Clinical Research Facility
mi
from
Orlando, FL
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated:  11/13/2017
Clinical Research Facility
mi
from
Port Orange, FL
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Clinical Research Facility
mi
from
Port Orange, FL
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated:  11/13/2017
Clinical Research Facility
mi
from
Trenton, NJ
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Clinical Research Facility
mi
from
Trenton, NJ
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated:  11/13/2017
Clinical Research Facility
mi
from
Calabash, NC
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Clinical Research Facility
mi
from
Calabash, NC
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated:  11/13/2017
Clinical Research Facility
mi
from
Portland, OR
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials